外泌體市場規模、佔有率和趨勢分析報告：按產品/服務、工作流程、應用、最終用途、地區和細分市場預測（2026-2033 年）

Exosomes Market Size, Share & Trends Analysis Report By Product & Service, By Workflow, By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033

出版日期: 2026年05月11日 | 出版商:

Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

外泌體市場概況

2025年全球外泌體市場規模估計為2.293億美元，預計2033年將達到12億美元。

預計從 2026 年到 2033 年，其複合年成長率將達到 23.0%。外泌體，也稱為細胞外囊泡 (EV)，由單層外膜包裹。

全球外泌體市場：基於工作流程的波動分析
全球外泌體市場：基於工作流程的規模和趨勢分析，2021-2033年
分離方法
- 超速離心
- 利用微珠的免疫清除方法
- 降水法
- 過濾
- 其他
下游分析
- 利用流式細胞技術進行細胞表面標誌物分析
- 利用印跡法和ELISA法進行蛋白質分析
- 利用NGS和PCR進行RNA分析
- 利用質譜進行蛋白質體學分析
- 其他

第6章外泌體市場：依應用分類的估算與趨勢分析

全球外泌體市場：基於應用的波動分析
全球外泌體市場：按應用領域分類的規模和趨勢分析（2021-2033年）
癌症
神經退化性疾病
心血管疾病
感染疾病
其他

第7章：外泌體市場：依最終用途分類的估算與趨勢分析

全球外泌體市場：依最終用途分類的波動分析
全球外泌體市場：依最終用途分類的規模和趨勢分析（2021-2033年）
製藥和生物技術公司
醫院和診斷中心
學術研究機構

第8章外泌體市場：區域估算與趨勢分析

2025年及2033年區域市佔率分析
區域市場概覽
市場規模、預測與趨勢分析，2021-2033年
北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 挪威
- 瑞典
- 丹麥
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 泰國
- 新加坡
拉丁美洲
- 巴西
- 阿根廷
中東和非洲
- 南非
- 沙烏地阿拉伯
- UAE
- 科威特

第9章競爭情勢

公司和競爭對手的分類
策略規劃
2025年公司市場分析
公司簡介列表
- Bio-Techne Corporation
- Danaher Corporation
- Hologic Inc.
- Fujifilm Holdings Corporation
- Lonza
- Miltenyi Biotec
- QIAGEN
- Thermo Fisher Scientific, Inc.
- Abcam Plc
- RoosterBio, Inc.

簡介目錄圖表

Product Code: GVR-2-68038-298-3

Exosomes Market Summary

The global exosomes market size was valued at USD 229.3 million in 2025 and is anticipated to reach USD 1.2 billion by 2033, growing at a CAGR of 23.0% between 2026 and 2033. Exosomes, also termed Extracellular Vesicles (EVs), are enclosed in a single outer membrane.

Global Exosomes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global exosomes market report based on product & service, workflow, application, end use, and region.

Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
Kits & Reagents
Instruments
Services
Workflow Outlook (Revenue, USD Million, 2021 - 2033)
Isolation Methods
- Ultracentrifugation
- Immunocapture on beads
- Precipitation
- Filtration
- Others
Downstream Analysis
- Cell surface marker analysis using flow cytometry
- Protein analysis using blotting & ELISA
- RNA analysis with NGS & PCR
- Proteomic analysis using mass spectroscopy
- Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Cancer
Neurodegenerative diseases
Cardiovascular diseases
Infectious diseases
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Pharmaceutical & biotechnology companies
Hospitals & diagnostics centers
Academic & research institutes
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Singapore
Latin America
- Brazil
- Argentina
MEA
- South Africa
- Saudi Arabia
- UAE
- Kuwait

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Workflow Segment
- 1.2.3. Application Segment
- 1.2.4. End Use Segment
1.3. Information analysis
- 1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
- 1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape

Chapter 3. Exosomes Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Advancements in Liquid Biopsy and Non-Invasive Diagnostics
  - 3.2.1.2. Growing Demand for Advanced Drug Delivery and Cancer Diagnostics
  - 3.2.1.3. Growth in government and non-government initiatives for exosome research
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent regulations pertaining to approval
  - 3.2.2.2. Challenges associated with the implementation of exosome-based therapies
- 3.2.3. Market Challenges Analysis
- 3.2.4. Market Opportunity Analysis
3.3. Case Study Insights
3.4. Exosomes Market Analysis Tools
- 3.4.1. Industry Analysis - Porter's Five Forces Analysis
- 3.4.2. PESTEL Analysis

Chapter 4. Exosomes Market: Product & Service Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Global Exosomes Market Product & Service Movement Analysis
4.3. Global Exosomes Market Size & Trend Analysis, by Product & Service, 2021 to 2033 (USD Million)
4.4. Kits & reagents
- 4.4.1. Kits & reagents market estimates and forecasts 2021 to 2033 (USD Million)
4.5. Instruments
- 4.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Services
- 4.6.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Exosomes Market: Workflow Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Global Exosomes Market Workflow Movement Analysis
5.3. Global Exosomes Market Size & Trend Analysis, by Workflow, 2021 to 2033 (USD Million)
5.4. Isolation Methods
- 5.4.1. Isolation methods market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.2. Ultracentrifugation
  - 5.4.2.1. Ultracentrifugation market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.3. Immunocapture on beads
  - 5.4.3.1. Immunocapture on beads market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.4. Precipitation
  - 5.4.4.1. Precipitation market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.5. Filtration
  - 5.4.5.1. Filtration market estimates and forecasts 2021 to 2033 (USD Million)
- 5.4.6. Others
  - 5.4.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
5.5. Downstream Analysis
- 5.5.1. Downstream analysis market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.2. Cell surface marker analysis using flow cytometry
  - 5.5.2.1. Cell surface marker analysis using flow cytometry market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.3. Protein Analysis using blotting & ELISA
  - 5.5.3.1. Protein Analysis using blotting & ELISA market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.4. RNA analysis with NGS & PCR
  - 5.5.4.1. RNA analysis with NGS & PCR market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.5. Proteomic analysis using mass spectroscopy
  - 5.5.5.1. Proteomic analysis using mass spectroscopy market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5.6. Others
  - 5.5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Exosomes Market: Application Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Global Exosomes Market Application Movement Analysis
6.3. Global Exosomes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Cancer
- 6.4.1. Cancer market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Neurodegenerative Diseases
- 6.5.1. Neurodegenerative diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Cardiovascular Diseases
- 6.6.1. Cardiovascular diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Infectious Diseases
- 6.7.1. Infectious diseases market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Others
- 6.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Exosomes Market: End Use Estimates & Trend Analysis

7.1. Segment Dashboard
7.2. Global Exosomes Market End Use Movement Analysis
7.3. Global Exosomes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Pharmaceutical & Biotechnology Companies
- 7.4.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
7.5. Hospitals & Diagnostics Centers
- 7.5.1. Hospitals & diagnostics centers market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Academic & Research Institutes
- 7.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Exosomes Market: Regional Estimates & Trend Analysis

8.1. Regional Market Share Analysis, 2025 & 2033
8.2. Regional Market Dashboard
8.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033
8.4. North America
- 8.4.1. North America market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.2. U.S.
  - 8.4.2.1. Key country dynamics
  - 8.4.2.2. Competitive scenario
  - 8.4.2.3. Regulatory Framework
  - 8.4.2.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.3. Canada
  - 8.4.3.1. Key country dynamics
  - 8.4.3.2. Competitive scenario
  - 8.4.3.3. Regulatory Framework
  - 8.4.3.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
- 8.4.4. Mexico
  - 8.4.4.1. Key country dynamics
  - 8.4.4.2. Competitive scenario
  - 8.4.4.3. Regulatory Framework
  - 8.4.4.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
8.5. Europe
- 8.5.1. Europe market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.2. UK
  - 8.5.2.1. Key country dynamics
  - 8.5.2.2. Competitive scenario
  - 8.5.2.3. Regulatory Framework
  - 8.5.2.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.3. Germany
  - 8.5.3.1. Key country dynamics
  - 8.5.3.2. Competitive scenario
  - 8.5.3.3. Regulatory Framework
  - 8.5.3.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.4. France
  - 8.5.4.1. Key country dynamics
  - 8.5.4.2. Competitive scenario
  - 8.5.4.3. Regulatory Framework
  - 8.5.4.4. France market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.5. Italy
  - 8.5.5.1. Key country dynamics
  - 8.5.5.2. Competitive scenario
  - 8.5.5.3. Regulatory Framework
  - 8.5.5.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.6. Spain
  - 8.5.6.1. Key country dynamics
  - 8.5.6.2. Competitive scenario
  - 8.5.6.3. Regulatory Framework
  - 8.5.6.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.7. Norway
  - 8.5.7.1. Key country dynamics
  - 8.5.7.2. Competitive scenario
  - 8.5.7.3. Regulatory Framework
  - 8.5.7.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.8. Sweden
  - 8.5.8.1. Key country dynamics
  - 8.5.8.2. Competitive scenario
  - 8.5.8.3. Regulatory Framework
  - 8.5.8.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
- 8.5.9. Denmark
  - 8.5.9.1. Key country dynamics
  - 8.5.9.2. Competitive scenario
  - 8.5.9.3. Regulatory Framework
  - 8.5.9.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Asia Pacific
- 8.6.1. Asia Pacific market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.2. Japan
  - 8.6.2.1. Key country dynamics
  - 8.6.2.2. Competitive scenario
  - 8.6.2.3. Regulatory Framework
  - 8.6.2.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.3. China
  - 8.6.3.1. Key country dynamics
  - 8.6.3.2. Competitive scenario
  - 8.6.3.3. Regulatory Framework
  - 8.6.3.4. China market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.4. India
  - 8.6.4.1. Key country dynamics
  - 8.6.4.2. Competitive scenario
  - 8.6.4.3. Regulatory Framework
  - 8.6.4.4. India market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.5. Australia
  - 8.6.5.1. Key country dynamics
  - 8.6.5.2. Competitive scenario
  - 8.6.5.3. Regulatory Framework
  - 8.6.5.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.6. South Korea
  - 8.6.6.1. Key country dynamics
  - 8.6.6.2. Competitive scenario
  - 8.6.6.3. Regulatory Framework
  - 8.6.6.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.7. Thailand
  - 8.6.7.1. Key country dynamics
  - 8.6.7.2. Competitive scenario
  - 8.6.7.3. Regulatory Framework
  - 8.6.7.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
- 8.6.8. Singapore
  - 8.6.8.1. Key country dynamics
  - 8.6.8.2. Competitive scenario
  - 8.6.8.3. Regulatory Framework
  - 8.6.8.4. Singapore market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Latin America
- 8.7.1. Latin America market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.2. Brazil
  - 8.7.2.1. Key country dynamics
  - 8.7.2.2. Competitive scenario
  - 8.7.2.3. Regulatory Framework
  - 8.7.2.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
- 8.7.3. Argentina
  - 8.7.3.1. Key country dynamics
  - 8.7.3.2. Competitive scenario
  - 8.7.3.3. Regulatory Framework
  - 8.7.3.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
8.8. MEA
- 8.8.1. MEA market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.2. South Africa
  - 8.8.2.1. Key country dynamics
  - 8.8.2.2. Competitive scenario
  - 8.8.2.3. Regulatory Framework
  - 8.8.2.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.3. Saudi Arabia
  - 8.8.3.1. Key country dynamics
  - 8.8.3.2. Competitive scenario
  - 8.8.3.3. Regulatory Framework
  - 8.8.3.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.4. UAE
  - 8.8.4.1. Key country dynamics
  - 8.8.4.2. Competitive scenario
  - 8.8.4.3. Regulatory Framework
  - 8.8.4.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 8.8.5. Kuwait
  - 8.8.5.1. Key country dynamics
  - 8.8.5.2. Competitive scenario
  - 8.8.5.3. Regulatory Framework
  - 8.8.5.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

9.1. Company/Competition Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles/Listing
- 9.4.1. Bio-Techne Corporation
  - 9.4.1.1. Company overview
  - 9.4.1.2. Financial performance
  - 9.4.1.3. Product benchmarking
  - 9.4.1.4. Strategic initiatives
- 9.4.2. Danaher Corporation
  - 9.4.2.1. Company overview
  - 9.4.2.2. Financial performance
  - 9.4.2.3. Product benchmarking
  - 9.4.2.4. Strategic initiatives
- 9.4.3. Hologic Inc.
  - 9.4.3.1. Company overview
  - 9.4.3.2. Financial performance
  - 9.4.3.3. Product benchmarking
  - 9.4.3.4. Strategic initiatives
- 9.4.4. Fujifilm Holdings Corporation
  - 9.4.4.1. Company overview
  - 9.4.4.2. Financial performance
  - 9.4.4.3. Product benchmarking
  - 9.4.4.4. Strategic initiatives
- 9.4.5. Lonza
  - 9.4.5.1. Company overview
  - 9.4.5.2. Financial performance
  - 9.4.5.3. Product benchmarking
  - 9.4.5.4. Strategic initiatives
- 9.4.6. Miltenyi Biotec
  - 9.4.6.1. Company overview
  - 9.4.6.2. Financial performance
  - 9.4.6.3. Product benchmarking
  - 9.4.6.4. Strategic initiatives
- 9.4.7. QIAGEN
  - 9.4.7.1. Company overview
  - 9.4.7.2. Financial performance
  - 9.4.7.3. Product benchmarking
  - 9.4.7.4. Strategic initiatives
- 9.4.8. Thermo Fisher Scientific, Inc.
  - 9.4.8.1. Company overview
  - 9.4.8.2. Financial performance
  - 9.4.8.3. Product benchmarking
  - 9.4.8.4. Strategic initiatives
- 9.4.9. Abcam Plc
  - 9.4.9.1. Company overview
  - 9.4.9.2. Financial performance
  - 9.4.9.3. Product benchmarking
  - 9.4.9.4. Strategic initiatives
- 9.4.10. RoosterBio, Inc.
  - 9.4.10.1. Company overview
  - 9.4.10.2. Financial performance
  - 9.4.10.3. Product benchmarking
  - 9.4.10.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 4 Global exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 5 Global exosomes market, by application, 2021 - 2033 (USD Million)
Table 6 Global exosomes market, by end use, 2021 - 2033 (USD Million)
Table 7 Global exosomes market, by region, 2021 - 2033 (USD Million)
Table 8 North America exosomes market, by country, 2021 - 2033 (USD Million)
Table 9 North America exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 10 North America exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 11 North America exosomes market, by application, 2021 - 2033 (USD Million)
Table 12 North America exosomes market, by end use, 2021 - 2033 (USD Million)
Table 13 U.S. exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 14 U.S. exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 15 U.S. exosomes market, by application, 2021 - 2033 (USD Million)
Table 16 U.S. exosomes market, by end use, 2021 - 2033 (USD Million)
Table 17 Canada exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 18 Canada exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 19 Canada exosomes market, by application, 2021 - 2033 (USD Million)
Table 20 Canada exosomes market, by end use, 2021 - 2033 (USD Million)
Table 21 Mexico exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 22 Mexico exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 23 Mexico exosomes market, by application, 2021 - 2033 (USD Million)
Table 24 Mexico exosomes market, by end use, 2021 - 2033 (USD Million)
Table 25 Europe exosomes market, by country, 2021 - 2033 (USD Million)
Table 26 Europe exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 27 Europe exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 28 Europe exosomes market, by application, 2021 - 2033 (USD Million)
Table 29 Europe exosomes market, by end use, 2021 - 2033 (USD Million)
Table 30 UK exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 31 UK exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 32 UK exosomes market, by application, 2021 - 2033 (USD Million)
Table 33 UK exosomes market, by end use, 2021 - 2033 (USD Million)
Table 34 Germany exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 35 Germany exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 36 Germany exosomes market, by application, 2021 - 2033 (USD Million)
Table 37 Germany exosomes market, by end use, 2021 - 2033 (USD Million)
Table 38 France exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 39 France exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 40 France exosomes market, by application, 2021 - 2033 (USD Million)
Table 41 France exosomes market, by end use, 2021 - 2033 (USD Million)
Table 42 Italy exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 43 Italy exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 44 Italy exosomes market, by application, 2021 - 2033 (USD Million)
Table 45 Italy exosomes market, by end use, 2021 - 2033 (USD Million)
Table 46 Spain exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 47 Spain exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 48 Spain exosomes market, by application, 2021 - 2033 (USD Million)
Table 49 Spain exosomes market, by end use, 2021 - 2033 (USD Million)
Table 50 Denmark exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 51 Denmark exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 52 Denmark exosomes market, by application, 2021 - 2033 (USD Million)
Table 53 Denmark exosomes market, by end use, 2021 - 2033 (USD Million)
Table 54 Sweden exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 55 Sweden exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 56 Sweden exosomes market, by application, 2021 - 2033 (USD Million)
Table 57 Sweden exosomes market, by end use, 2021 - 2033 (USD Million)
Table 58 Norway exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 59 Norway exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 60 Norway exosomes market, by application, 2021 - 2033 (USD Million)
Table 61 Norway exosomes market, by end use, 2021 - 2033 (USD Million)
Table 62 Asia Pacific exosomes market, by country, 2021 - 2033 (USD Million)
Table 63 Asia Pacific exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 64 Asia Pacific exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 65 Asia Pacific exosomes market, by application, 2021 - 2033 (USD Million)
Table 66 Asia Pacific exosomes market, by end use, 2021 - 2033 (USD Million)
Table 67 Japan exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 68 Japan exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 69 Japan exosomes market, by application, 2021 - 2033 (USD Million)
Table 70 Japan exosomes market, by end use, 2021 - 2033 (USD Million)
Table 71 China exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 72 China exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 73 China exosomes market, by application, 2021 - 2033 (USD Million)
Table 74 China exosomes market, by end use, 2021 - 2033 (USD Million)
Table 75 India exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 76 India exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 77 India exosomes market, by application, 2021 - 2033 (USD Million)
Table 78 India exosomes market, by end use, 2021 - 2033 (USD Million)
Table 79 Australia exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 80 Australia exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 81 Australia exosomes market, by application, 2021 - 2033 (USD Million)
Table 82 Australia exosomes market, by end use, 2021 - 2033 (USD Million)
Table 83 Thailand exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 84 Thailand exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 85 Thailand exosomes market, by application, 2021 - 2033 (USD Million)
Table 86 Thailand exosomes market, by end use, 2021 - 2033 (USD Million)
Table 87 South Korea exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 88 South Korea exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 89 South Korea exosomes market, by application, 2021 - 2033 (USD Million)
Table 90 South Korea exosomes market, by end use, 2021 - 2033 (USD Million)
Table 91 Singapore exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 92 Singapore exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 93 Singapore exosomes market, by application, 2021 - 2033 (USD Million)
Table 94 Singapore exosomes market, by end use, 2021 - 2033 (USD Million)
Table 95 Latin America exosomes market, by country, 2021 - 2033 (USD Million)
Table 96 Latin America exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 97 Latin America exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 98 Latin America exosomes market, by application, 2021 - 2033 (USD Million)
Table 99 Latin America exosomes market, by end use, 2021 - 2033 (USD Million)
Table 100 Brazil exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 101 Brazil exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 102 Brazil exosomes market, by application, 2021 - 2033 (USD Million)
Table 103 Brazil exosomes market, by end use, 2021 - 2033 (USD Million)
Table 104 Argentina exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 105 Argentina exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 106 Argentina exosomes market, by application, 2021 - 2033 (USD Million)
Table 107 Argentina exosomes market, by end use, 2021 - 2033 (USD Million)
Table 108 Middle East & Africa exosomes market, by country, 2021 - 2033 (USD Million)
Table 109 Middle East & Africa exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 110 Middle East & Africa exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 111 Middle East & Africa exosomes market, by application, 2021 - 2033 (USD Million)
Table 112 Middle East & Africa exosomes market, by end use, 2021 - 2033 (USD Million)
Table 113 South Africa exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 114 South Africa exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 115 South Africa exosomes market, by application, 2021 - 2033 (USD Million)
Table 116 South Africa exosomes market, by end use, 2021 - 2033 (USD Million)
Table 117 Saudi Arabia exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 118 Saudi Arabia exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 119 Saudi Arabia exosomes market, by application, 2021 - 2033 (USD Million)
Table 120 Saudi Arabia exosomes market, by end use, 2021 - 2033 (USD Million)
Table 121 UAE exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 122 UAE exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 123 UAE exosomes market, by application, 2021 - 2033 (USD Million)
Table 124 UAE exosomes market, by end use, 2021 - 2033 (USD Million)
Table 125 Kuwait exosomes market, by product & service, 2021 - 2033 (USD Million)
Table 126 Kuwait exosomes market, by workflow, 2021 - 2033 (USD Million)
Table 127 Kuwait exosomes market, by application, 2021 - 2033 (USD Million)
Table 128 Kuwait exosomes market, by end use, 2021 - 2033 (USD Million)

List of Figures

Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market outlook
Fig. 9 Market segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Porter's five forces analysis
Fig. 13 PESTEL analysis
Fig. 14 Exosomes market: Product & service outlook and key takeaways
Fig. 15 Exosomes market: Product & service movement analysis
Fig. 16 Global kits & reagents market, 2021 - 2033 (USD Million)
Fig. 17 Global instruments market, 2021 - 2033 (USD Million)
Fig. 18 Global services market, 2021 - 2033 (USD Million)
Fig. 19 Exosomes market: Workflow outlook and key takeaways
Fig. 20 Exosomes market: Workflow movement analysis
Fig. 21 Global isolation methods market, 2021 - 2033 (USD Million)
Fig. 22 Global ultracentrifugation market, 2021 - 2033 (USD Million)
Fig. 23 Global immunocapture on beads market, 2021 - 2033 (USD Million)
Fig. 24 Global precipitation market, 2021 - 2033 (USD Million)
Fig. 25 Global filtration market, 2021 - 2033 (USD Million)
Fig. 26 Global others market, 2021 - 2033 (USD Million)
Fig. 27 Global downstream analysis market, 2021 - 2033 (USD Million)
Fig. 28 Global cell surface marker analysis using flow cytometry market, 2021 - 2033 (USD Million)
Fig. 29 Global protein analysis using blotting & ELISA market, 2021 - 2033 (USD Million)
Fig. 30 Global RNA analysis with NGS & PCR market, 2021 - 2033 (USD Million)
Fig. 31 Global proteomic analysis using mass spectroscopy market, 2021 - 2033 (USD Million)
Fig. 32 Global others market, 2021 - 2033 (USD Million)
Fig. 33 Exosomes market: Application outlook and key takeaways
Fig. 34 Exosomes market: Application movement analysis
Fig. 35 Global cancer market, 2021 - 2033 (USD Million)
Fig. 36 Global neurodegenerative diseases market, 2021 - 2033 (USD Million)
Fig. 37 Global cardiovascular diseases market, 2021 - 2033 (USD Million)
Fig. 38 Global infectious diseases market, 2021 - 2033 (USD Million)
Fig. 39 Global others market, 2021 - 2033 (USD Million)
Fig. 40 Exosomes market: End Use outlook and key takeaways
Fig. 41 Exosomes market: End Use movement analysis
Fig. 42 Global pharmaceutical & biotechnology companies market, 2021 - 2033 (USD Million)
Fig. 43 Global hospitals & diagnostics centers market, 2021 - 2033 (USD Million)
Fig. 44 Global academic & research institutes market, 2021 - 2033 (USD Million)
Fig. 45 Exosomes market: Regional outlook and key takeaways
Fig. 46 North America exosomes market, 2021 - 2033 (USD Million)
Fig. 47 U.S. key country dynamics
Fig. 48 U.S. exosomes market, 2021 - 2033 (USD Million)
Fig. 49 Canada key country dynamics
Fig. 50 Canada exosomes market, 2021 - 2033 (USD Million)
Fig. 51 Mexico key country dynamics
Fig. 52 Mexico exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 Europe exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 54 UK key country dynamics
Fig. 55 UK exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 56 Germany key country dynamics
Fig. 57 Germany exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 58 France key country dynamics
Fig. 59 France exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 60 Italy key country dynamics
Fig. 61 Italy exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 62 Spain key country dynamics
Fig. 63 Spain exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 64 Denmark key country dynamics
Fig. 65 Denmark exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 66 Sweden key country dynamics
Fig. 67 Sweden exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 68 Norway key country dynamics
Fig. 69 Norway exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 70 Asia-Pacific exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 71 Japan key country dynamics
Fig. 72 Japan exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 73 China key country dynamics
Fig. 74 China exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 75 India key country dynamics
Fig. 76 India exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 77 Australia key country dynamics
Fig. 78 Australia exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 79 Thailand key country dynamics
Fig. 80 Thailand exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 81 South Korea key country dynamics
Fig. 82 South Korea exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 83 Singapore key country dynamics
Fig. 84 Singapore exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 85 Latin America exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 86 Brazil key country dynamics
Fig. 87 Brazil exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 88 Argentina key country dynamics
Fig. 89 Argentina exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 90 MEA exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 91 South Africa key country dynamics
Fig. 92 South Africa exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 93 Saudi Arabia key country dynamics
Fig. 94 Saudi Arabia exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 95 UAE key country dynamics
Fig. 96 UAE exosomes market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 97 Kuwait key country dynamics
Fig. 98 Kuwait exosomes market estimates and forecast, 2021 - 2033 (USD Million)